- Home
- OABI vs LCNB Comparison
OABI vs LCNB Comparison
Compare OABI & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- LCNB
- Stock Information
- Founded
- OABI 2012
- LCNB 1877
- Country
- OABI United States
- LCNB United States
- Employees
- OABI 114
- LCNB N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- LCNB Major Banks
- Sector
- OABI Health Care
- LCNB Finance
- Exchange
- OABI Nasdaq
- LCNB Nasdaq
- Market Cap
- OABI 239.0M
- LCNB 205.5M
- IPO Year
- OABI N/A
- LCNB N/A
- Fundamental
- Price
- OABI $1.65
- LCNB $14.80
- Analyst Decision
- OABI Strong Buy
- LCNB
- Analyst Count
- OABI 3
- LCNB 0
- Target Price
- OABI $6.67
- LCNB N/A
- AVG Volume (30 Days)
- OABI 525.9K
- LCNB 23.2K
- Earning Date
- OABI 11-04-2025
- LCNB 10-20-2025
- Dividend Yield
- OABI N/A
- LCNB 5.98%
- EPS Growth
- OABI N/A
- LCNB 186.06
- EPS
- OABI N/A
- LCNB 1.49
- Revenue
- OABI $23,027,000.00
- LCNB $86,864,000.00
- Revenue This Year
- OABI N/A
- LCNB $17.01
- Revenue Next Year
- OABI $48.74
- LCNB $5.83
- P/E Ratio
- OABI N/A
- LCNB $9.87
- Revenue Growth
- OABI 6.05
- LCNB 22.73
- 52 Week Low
- OABI $1.22
- LCNB $13.34
- 52 Week High
- OABI $4.87
- LCNB $17.92
- Technical
- Relative Strength Index (RSI)
- OABI 48.14
- LCNB 45.63
- Support Level
- OABI $1.64
- LCNB $14.42
- Resistance Level
- OABI $1.76
- LCNB $14.99
- Average True Range (ATR)
- OABI 0.10
- LCNB 0.33
- MACD
- OABI 0.01
- LCNB 0.01
- Stochastic Oscillator
- OABI 23.44
- LCNB 67.51
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.